Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of September 2026
John Fourier @John Fourier
Gold member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,581,333talents

Virtual portfolio value:

$5,334,080talents

Net overall return per annum:

18.90%

AYA current rank order:

#16

Asset investment philosophy:
John Fourier trades U.S. stocks with the top #276 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
MGRT Mega Fortune Company Limited Ordinary Shares $6.46 $135.97 2,176 +2,004.80% $281,814
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 129,826 +793.33% $154,493
TOP TOP Financial Group Limited Class A Ordinary Shares $2.06 $16.73 9,278 +712.14% $136,108
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 45,111 +833.33% $135,333
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 45,111 +833.33% $135,333
VATE INNOVATE Corp. Common Stock $0.53 $4.14 36,743 +681.13% $132,642
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 857 +601.88% $95,890
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 9,925 +2,108.33% $75,331
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,441 +590.22% $39,123
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 951 +589.24% $39,058
Sum $1,225,125

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$ZIM

Blog+More

A small fraction of the population enjoys most capital and wealth creation.

Jacob Miramar

2017-03-15 08:46:00 Wednesday ET

A small fraction of the population enjoys most capital and wealth creation.

The heuristic rule of *accumulative advantage* suggests that a small fraction of the population enjoys a large proportion of both capital and wealth creatio

+See More

The Chinese new star board launches for tech firms to list at home.

Daphne Basel

2019-07-09 15:14:00 Tuesday ET

The Chinese new star board launches for tech firms to list at home.

The Chinese new star board launches for tech firms to list at home. The Nasdaq-equivalent new star board serves as a key avenue for Chinese tech companies t

+See More

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of Amazon (U.S. stock symbol: $AMZN).

Dan Rochefort

2025-09-14 14:23:00 Sunday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of Amazon (U.S. stock symbol: $AMZN).

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund

+See More

The Trump team receives a 3.2% first-quarter GDP boost as Federal Reserve halts the next interest rate hike in May 2019.

Olivia London

2019-05-07 09:30:00 Tuesday ET

The Trump team receives a 3.2% first-quarter GDP boost as Federal Reserve halts the next interest rate hike in May 2019.

The Trump team receives a 3.2% first-quarter GDP boost as Fed Chair Jay Powell halts the next interest rate hike in early-May 2019. This smooth upward econo

+See More

Presidents Trump and Xi agree on an interim trade truce at the G20 summit in Argentina.

Apple Boston

2018-12-09 08:44:00 Sunday ET

Presidents Trump and Xi agree on an interim trade truce at the G20 summit in Argentina.

President Trump meets with Chinese President Xi again at the G20 summit in the city of Buenos Aires, Argentina, in late-November 2018. President Donald Trum

+See More

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

Monica McNeil

2025-10-31 12:26:00 Friday ET

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi

+See More